Skip to main content
. 2022 May;10(9):519. doi: 10.21037/atm-22-1430

Figure 2.

Figure 2

Overexpression of SLC2A1 indicated poor prognosis in LUAD. (A) Forest plots with univariate Cox regression for SLC2A1 and clinical factors; (B) Forest plots with multivariate Cox regression incorporating SLC2A1 and clinical factors; (C-O) high expression of SLC2A1 predicted poor OS and PFS in both the overall samples and each subgroup samples in the Kaplan-Meier Plotter; (P) the high SLC2A1 expression group had significantly worse OS than the low SLC2A1 expression group in GEPIA; (Q) the PFS of the two groups did not exhibit significant differences in the logrank test by GEPIA. LUAD, lung adenocarcinoma; OS, overall survival; PFS, progression free survival; GEPIA, Gene Expression Profiling Interactive Analysis.